Treatment for Pseudogout
The first-line treatment for acute pseudogout includes NSAIDs, low-dose colchicine, or glucocorticoids (oral or intra-articular injection), with the specific choice based on patient comorbidities and contraindications. 1
Acute Management Options
First-line Treatments
NSAIDs
Colchicine
- Low-dose regimen preferred: 1.2 mg initially, followed by 0.6 mg one hour later (total 1.8 mg)
- Must be started within 36 hours of symptom onset for maximum effectiveness
- Avoid high doses due to significant gastrointestinal side effects (diarrhea, nausea, vomiting) 1
- Traditional high-dose regimens are no longer recommended due to toxicity 2
Glucocorticoids
Adjunctive Therapy
- Topical ice application can provide additional symptom relief 1
- Rest and elevation of the affected joint
Severe or Resistant Cases
- Combination therapy may be used for severe attacks (pain ≥7/10) or polyarticular involvement 1
- IL-1 inhibitors (anakinra) have shown effectiveness in treatment-resistant pseudogout 3
Prophylactic Treatment
For patients with recurrent attacks of pseudogout:
- Low-dose colchicine (0.6 mg once or twice daily) has been shown to reduce attack frequency from 3.2 to 1 attack per patient per year 4
- NSAIDs at lower doses can also be used for prophylaxis
- Prophylaxis duration: Usually 3-6 months, depending on clinical response 1
Special Considerations
Post-surgical Pseudogout
- Pseudogout can occur as a complication after surgeries, particularly parathyroidectomy and knee arthroplasty 5, 6
- Prophylactic colchicine (1 mg/day) may prevent post-surgical attacks in at-risk patients 6
Addressing Underlying Conditions
- Evaluate for and treat associated conditions that can trigger pseudogout:
- Hyperparathyroidism
- Hemochromatosis
- Hypophosphatasia
- Hypomagnesemia
Common Pitfalls to Avoid
Misdiagnosing as infection: Always consider joint aspiration and crystal analysis to differentiate pseudogout from septic arthritis 5
Using high-dose colchicine regimens: These cause significant toxicity with minimal additional benefit 2, 1
Inadequate treatment duration: Premature discontinuation of therapy can lead to symptom recurrence
Overlooking prophylaxis: Patients with frequent recurrences benefit from preventive therapy 4
Neglecting lifestyle modifications: Weight loss (if obese), adequate hydration, and dietary modifications should be incorporated into the management plan 1